Relationship between CRP Albumin Ratio and the Mortality in Critically Ill Patients with AKI: A Retrospective Observational Study.
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2021
2021
Historique:
received:
23
03
2021
accepted:
11
09
2021
entrez:
11
10
2021
pubmed:
12
10
2021
medline:
12
1
2022
Statut:
epublish
Résumé
AKI is known to be associated with inflammation and nutritional status. The novel inflammatory prognostic score CAR (CRP/albumin ratio), which combines inflammation and nutritional status, was hypothesized to be associated with mortality in critically ill AKI patients in this study. The included cases were patients admitted to the ICU of Shandong Provincial Hospital from January 2016 to November 2018 and diagnosed with AKI within 48 hours of ICU admission. From the electronic case database of Shandong Provincial Hospital, we extracted the baseline demographic information, vital signs, routine laboratory parameters, complications, and other data. The above records are measured within 48 hours of admission to ICU. The clinical endpoint was the total cause mortality rate in hospital and 2 years. We constructed two multivariate regression models to determine the statistically significant correlation between CAR and mortality and conducted subgroup analysis to determine the mortality among different subgroups. A total of 580 patients were included in this study. In multivariate regression analysis, higher CAR was associated with an increase in hospital and two-year all-cause mortality in critically ill patients with AKI after adjusting gender, age, respiratory frequency, temperature, and other confounding factors (tertile 3 versus tertile 1: OR, 95% CI: 2.97, 1.70-5.17; 3.03, 1.68-5.47, respectively; The increase of CAR in critically ill patients with AKI was associated with an increased risk of all-cause death.
Sections du résumé
BACKGROUND
BACKGROUND
AKI is known to be associated with inflammation and nutritional status. The novel inflammatory prognostic score CAR (CRP/albumin ratio), which combines inflammation and nutritional status, was hypothesized to be associated with mortality in critically ill AKI patients in this study.
METHODS
METHODS
The included cases were patients admitted to the ICU of Shandong Provincial Hospital from January 2016 to November 2018 and diagnosed with AKI within 48 hours of ICU admission. From the electronic case database of Shandong Provincial Hospital, we extracted the baseline demographic information, vital signs, routine laboratory parameters, complications, and other data. The above records are measured within 48 hours of admission to ICU. The clinical endpoint was the total cause mortality rate in hospital and 2 years. We constructed two multivariate regression models to determine the statistically significant correlation between CAR and mortality and conducted subgroup analysis to determine the mortality among different subgroups.
RESULTS
RESULTS
A total of 580 patients were included in this study. In multivariate regression analysis, higher CAR was associated with an increase in hospital and two-year all-cause mortality in critically ill patients with AKI after adjusting gender, age, respiratory frequency, temperature, and other confounding factors (tertile 3 versus tertile 1: OR, 95% CI: 2.97, 1.70-5.17; 3.03, 1.68-5.47, respectively;
CONCLUSION
CONCLUSIONS
The increase of CAR in critically ill patients with AKI was associated with an increased risk of all-cause death.
Identifiants
pubmed: 34631892
doi: 10.1155/2021/9957563
pmc: PMC8497108
doi:
Substances chimiques
Albumins
0
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
9957563Informations de copyright
Copyright © 2021 Jiajia Wang et al.
Déclaration de conflit d'intérêts
There is no conflict of interest regarding the publication of this paper.
Références
Kidney Int. 2008 Mar;73(5):538-46
pubmed: 18160961
Intensive Care Med. 2017 Jun;43(6):956
pubmed: 28321464
J Clin Gastroenterol. 2018 Jul;52(6):e48-e52
pubmed: 28737646
Curr Vasc Pharmacol. 2013 Mar 1;11(2):187-95
pubmed: 23506497
Crit Care. 2019 Apr 8;23(1):112
pubmed: 30961662
PLoS One. 2017 Jul 19;12(7):e0180750
pubmed: 28723973
Hepatobiliary Pancreat Dis Int. 2017 Aug 15;16(4):424-430
pubmed: 28823374
Eur J Pediatr. 2017 Jun;176(6):745-755
pubmed: 28409285
Intensive Care Med. 2010 Oct;36(10):1657-65
pubmed: 20517593
Nephrology (Carlton). 2018 Oct;23 Suppl 4:50-52
pubmed: 30298655
J Nephrol. 2012 May-Jun;25(3):332-40
pubmed: 21928234
Clin J Am Soc Nephrol. 2013 Feb;8(2):194-202
pubmed: 23124779
Angiology. 2015 Sep;66(8):732-7
pubmed: 25260710
Nutr Clin Pract. 2005 Aug;20(4):369-76
pubmed: 16207677
Kidney Int. 2004 Oct;66(4):1613-21
pubmed: 15458458
Ann Intern Med. 2017 Nov 7;167(9):ITC66-ITC80
pubmed: 29114754
Ann Surg Oncol. 2015 Mar;22(3):803-10
pubmed: 25190127
Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2476-82
pubmed: 16931792
Am J Epidemiol. 1993 Dec 1;138(11):923-36
pubmed: 8256780
Heart Lung Circ. 2019 Nov;28(11):1638-1645
pubmed: 30293924
Best Pract Res Clin Anaesthesiol. 2009 Jun;23(2):183-91
pubmed: 19653438
Sci Rep. 2015 Jun 18;5:10481
pubmed: 26084991
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Nephrol Dial Transplant. 2008 Jul;23(7):2235-41
pubmed: 18408072
PLoS One. 2013;8(3):e59321
pubmed: 23555017
PLoS One. 2012;7(6):e35838
pubmed: 22701553
Am J Respir Crit Care Med. 2013 Mar 1;187(5):509-17
pubmed: 23348975
Annu Rev Physiol. 2019 Feb 10;81:309-333
pubmed: 30742783
Am Heart J. 2009 Oct;158(4):659-66
pubmed: 19781428
Crit Care. 2006;10(3):R73
pubmed: 16696865
Rev Invest Clin. 1994 Jan-Feb;46(1):37-43
pubmed: 8079062
Inflamm Res. 2013 Oct;62(10):887-94
pubmed: 23872926
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Rev Port Cardiol (Engl Ed). 2019 Apr;38(4):269-277
pubmed: 31104927
Lancet. 2012 Aug 25;380(9843):756-66
pubmed: 22617274
J Clin Med. 2019 Dec 12;8(12):
pubmed: 31842300
PLoS One. 2018 Jun 21;13(6):e0199153
pubmed: 29927987
Pediatr Nephrol. 2007 Oct;22(10):1655-8
pubmed: 17665221
Tumour Biol. 2016 Sep;37(9):12525-12533
pubmed: 27344157